NCT01844752View on ClinicalTrials.gov

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

PHASE2CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

NVN1000 1% Gel

Twice daily NVN1000 1% Gel for 12 weeks

DRUG

NVN1000 4% Gel

Twice daily NVN1000 4% Gel for 12 weeks

DRUG

Vehicle Gel

Twice daily Vehicle Gel for 12 weeks

Trial Locations (3)

Unknown

Instituto Dermatologico & Cirugia de Piel, Santo Domingo

Hospital Y Clinica Bendana, San Pedro Sula

Hosptal Punta Pacifica, Panama City

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT01844752 - A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne | Biotech Hunter | Biotech Hunter